BIOMAT Database Logo BIOMAT Database Logo

Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase. 1995

K E Bethin, and N Petrovic, and M J Ettinger
Department of Biochemistry, State University of New York at Buffalo 14214, USA.

The properties of a mouse liver copper binding protein (CuBP) and human placental S-adenosylhomocysteine hydrolase (SAHH) were compared to test the hypothesis that CuBP is SAHH. CuBP and SAHH migrated identically on SDS-polyacrylamide gel electrophoresis gels, and their 48-kDa monomers both self-associate to tetramers. Human placental SAHH cross-reacted with polyclonal antibodies to mouse liver CuBP, and CuBP from mouse liver cross-reacted with two monoclonal antibodies to human placental SAHH. A third monoclonal antibody to human placenta SAHH reacted weakly with the mouse liver protein but well with CuBP from human lymphoblasts. NAD(+)-activated CuBP has high SAHH enzymatic activity. Moreover, human placental SAHH, like mouse liver CuBP, has a single high affinity copper binding site per 48-kDa subunit. Thus, the data confirm that CuBP is SAHH, and SAHH is proposed to be a bifunctional protein with roles in sulfur-amino acid metabolism and copper metabolism. The copper binding activity of SAHH is proposed to play a significant role in the intracellular distribution of copper, and SAHH enzymatic activity may influence copper metabolism through its role in cysteine biosynthesis from methionine.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning

Related Publications

K E Bethin, and N Petrovic, and M J Ettinger
Copper binding to mouse liver S-adenosylhomocysteine hydrolase and the effects of copper on its levels.
September 1995, The Journal of biological chemistry,
K E Bethin, and N Petrovic, and M J Ettinger
Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiency.
August 2011, Electrophoresis,
K E Bethin, and N Petrovic, and M J Ettinger
S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity.
November 1978, Science (New York, N.Y.),
K E Bethin, and N Petrovic, and M J Ettinger
Substrate binding stabilizes S-adenosylhomocysteine hydrolase in a closed conformation.
August 2000, Biochemistry,
K E Bethin, and N Petrovic, and M J Ettinger
Truncated fluorocyclopentenyl pyrimidines as S-adenosylhomocysteine hydrolase inhibitors.
May 2009, Nucleosides, nucleotides & nucleic acids,
K E Bethin, and N Petrovic, and M J Ettinger
Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase.
September 1982, Pharmacological reviews,
K E Bethin, and N Petrovic, and M J Ettinger
Carbocyclic pyrimidine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase.
December 2006, Bioorganic & medicinal chemistry,
K E Bethin, and N Petrovic, and M J Ettinger
S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.
January 2004, Medical hypotheses,
K E Bethin, and N Petrovic, and M J Ettinger
S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action.
June 2004, Trends in pharmacological sciences,
K E Bethin, and N Petrovic, and M J Ettinger
S-adenosylhomocysteine-hydrolase from bovine kidney: enzymatic and binding properties.
January 1996, Kidney & blood pressure research,
Copied contents to your clipboard!